Novo Nordisk and Microsoft to collaborate on drug development using AI
The Danish drugmaker’s research and development division gains access to Microsoft’s data and knowledge of artificial intelligence.
by marketwire, translated by daniel pedersen
On Monday, Novo Nordisk and Microsoft announced in a press release a new strategic collaboration that will combine the pharmaceutical firm’s drug discovery machine with the tech giant’s artificial intelligence and cloud services.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.